The Regulation of Inflammatory Mediators in Acute Kidney Injury via Exogenous Mesenchymal Stem Cells
Acute kidney injury (AKI) remains to be an independent risk factor for mortality and morbidity. Inflammation is believed to play a major role in the pathophysiology of AKI. Exogenous mesenchymal stem cells (MSCs) are now under extensive investigation as a potential therapy for AKI. Various preclinic...
Main Authors: | Tao Du, Ying-Jian Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/261697 |
Similar Items
-
Immunomodulatory Effects of Mesenchymal Stem Cells on Drug-Induced Acute Kidney Injury
by: Qiuxia Han, et al.
Published: (2021-06-01) -
Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy
by: Wei-Cheng Tseng, et al.
Published: (2021-06-01) -
Mesenchymal stem cell therapy targeting mitochondrial dysfunction in acute kidney injury
by: Lingfei Zhao, et al.
Published: (2019-05-01) -
Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury
by: Song Zhou, et al.
Published: (2020-11-01) -
Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity
by: Kenji Tsuji, et al.
Published: (2018-01-01)